Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Kyriacos Mitrophanous, Philip C. Buttery et al.|The Lancet|2014Cited by 436
Paroxysmal positive symptoms caused by hardware malfunctioning in deep brain stimulationDaniel Ciampi de Andrade, Stéphane Palfi, Colette Goujon et al.|Brain stimulation|2009Cited by 3